Janssen (Johnson & Johnson): Ad26.COV2.S

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Ad26COVS1, JNJ-78436735

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 5 Trials

Phase 2: 8 Trials

Phase 3: 8 Trials

Registered Trials